Dr. Vijay Trisal, MD

Dr. Trisal practices at City of Hope Comprehensive Cancer Center - Duarte in Duarte, California.

Dr. Trisal's NPI, 1134225683, was assigned on September 15, 2006. Dr. Trisal graduated from Government Medical College of Jammu and Kashmire in 1993. Dr. Trisal holds California license A78977.

Dr. Trisal's primary practice is City of Hope Comprehensive Cancer Center - Duarte, at 1500 Duarte Rd, Duarte, CA 91010 in Los Angeles County. The practice phone is (800) 826-4673.

Dr. Trisal's primary practice is City of Hope Comprehensive Cancer Center - Duarte in Duarte, California. Dr. Trisal is also affiliated with City of Hope Cancer Center Atlanta. The medical group on file is City of Hope. Dmand AI also links Dr. Trisal to 1 more other site and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Trisal practices, 2 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Trisal's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Trisal is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Trisal's licenses on file in 2 states: California and Michigan.

Dmand AI lists cancerous skin growth removal among the conditions Dr. Trisal treats.

CMS data shows 36 Medicare services from Dr. Trisal across 2 procedure codes in 2024, all of them office visits, for 42 Medicare patients. Medicare paid $2,786 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 42 Medicare patients who saw Dr. Trisal in 2024. The largest group is 65 to 74, with 20 patients. 75% of them have high cholesterol, and 69% have high blood pressure. Their average risk score is 1.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Trisal's median patient age at 70, with 63% women.

In 2017, Dr. Trisal wrote 12 Medicare Part D claims. They cover 1 drug, with $6,015 in total drug cost. In 2016, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Trisal for performance year 2024, reported as part of a group. Dr. Trisal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Trisal as offering telehealth. CMS counts 15 procedures of mastectomy by Dr. Trisal, more than 72% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 22 papers to Dr. Trisal, published from 2011 to 2025. 2013 was the busiest year, with 2. The most frequent topics are Melanoma, Biomarkers, Tumor and Breast Neoplasms. Dr. Trisal has published most often in Am Surg. Dr. Trisal's most frequent co-authors are William E. Carson, MD, Kenneth Kenji Tanabe, MD and Daniel G. Coit, MD.

CMS Open Payments shows 11 general payments to Dr. Trisal from 4 drug and device companies from 2018 to 2024. Honoraria make up the largest share, 73% of the total. Iovance Biotherapeutics, Inc. paid the most, $4,738.

Dr. Trisal graduated from Government Medical College of Jammu and Kashmire in 1993.

Dr. Trisal is in network with 5 carriers, including Aetna, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.